Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Turcot syndrome 1Lymphatic Metastasis 1

Interventions

Specimen Handling 78Cisplatin 66Carboplatin 64Drug Therapy 63Magnetic Resonance Spectroscopy 62Bevacizumab 62Radiotherapy 57Cyclophosphamide 56Gemcitabine 54pembrolizumab 52Capecitabine 50Oxaliplatin 49toripalimab 45Paclitaxel 41tislelizumab 40Standard of Care 39Biopsy 37fludarabine 36Injections 36Fluorouracil 34venetoclax 33Blood Specimen Collection 31Immune Checkpoint Inhibitors 30anlotinib 29Docetaxel 28Surgical Procedures, Operative 27Leucovorin 27Irinotecan 27Dexamethasone 27Nivolumab 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × DNA Mismatch Repair × 1 year × Clear all
NCT07625735 2026-06-04

MMR Status Modulates the Predictive Value of Lymphatic Invasion for Lymph Node Metastasis in Gastric Cancer

Shanghai Zhongshan Hospital

Not yet recruiting
3,000 enrolled

Turcot syndrome, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡